• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10602
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/03/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.
 
Event or Problem Description
It was reported that shaft break occurred.The 80% target lesion was located in the moderately tortuous and moderately calcified coronary artery.A 2.50 x 16 synergy drug-eluting stent was advanced for treatment.However, during procedure the shaft broke when trying to deliver the stent.The procedure was completed with a different device.No patient complications were reported.
 
Additional Manufacturer Narrative
Device is a combination product.Device evaluated by mfr:synergy ii us mr 2.50 x 16 mm stent delivery system catheter was returned for analysis.An examination of the crimped stent found stent damage.Stent struts on distal end of stent flared and proximal struts raised and pulled distally.The undamaged crimped stent outer diameter was measured and the result was within max crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of tip damage.A visual and tactile examination of the hypotube shaft found multiple kinks along several locations of the hypotube shaft.Also noted during analysis was a break situated at 76cm distal to the distal end of the strain relief.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that shaft break occurred.The 80% target lesion was located in the moderately tortuous and moderately calcified coronary artery.A 2.50 x 16 synergy drug-eluting stent was advanced for treatment.However, during procedure the shaft broke when trying to deliver the stent.The procedure was completed with a different device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9741060
Report Number2134265-2020-01693
Device Sequence Number1802021
Product Code NIQ
UDI-Device Identifier08714729840091
UDI-Public08714729840091
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/29/2021
Device Model Number10602
Device Catalogue Number10602
Device Lot Number0024732595
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/06/2020
Initial Date Received by Manufacturer 02/03/2020
Supplement Date Received by Manufacturer04/30/2020
Initial Report FDA Received Date02/21/2020
Supplement Report FDA Received Date05/28/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-